author-photo

Chiara Senti

20

Papers

89

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Abstract 28: Prognostic value of baseline and early changes of circulating cell-free (cf)DNA in the neoadjuvant setting of early stage colon cancer (CC)

2021
Show All
- Source
- Cite
- Save
Citations (0)
505TiP REGINA: A phase II trial of neoadjuvant regorafenib (rego) in combination with nivolumab (nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Is there a correlation between clinic-pathological features, MSI, PD-L1 and survival outcomes in resected gastric cancer? Looking for optimal biomarkers.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
688PCorrelation between clinic-pathological features, MSI, PD-L1 and survival in resectable gastric cancer: Looking for prognostic biomarkers

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
D22Prognostic factors associated with survival and recurrence in resectable gastroesophageal cancer: retrospective analysis of 338 patients operated at the Hospital of Cremona in ten years' time

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic factors associated with survival and recurrence in resectable gastroesophageal adenocarcinoma: retrospective analysis of 497 patients operated at two Italian centers

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers

2016 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (4)
A Phase II study of olaparib in breast cancer patients: biological evaluation from a ‘window of opportunity’ trial

2016 Future Oncology
Show All
- Source
- Cite
- Save
Citations (6)
No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials

2016 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (10)